Regulation of p38 MAP kinase in CD4+ lymphocytes by infliximab therapy in patients with rheumatoid arthritis
✍ Scribed by Bruce E. Garfield; Troy Krahl; Stacia Appel; Sheldon M. Cooper; Mercedes Rincón
- Book ID
- 116366352
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 285 KB
- Volume
- 116
- Category
- Article
- ISSN
- 1090-2341
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective According to the Centers for Disease Control and Prevention, the 1999 and 2000 incidence rates for tuberculosis (TB) in the US population were 6.4 and 5.8, respectively, per 100,000 persons. Recently, reports of TB following infliximab administration have raised questions
## Abstract In the present study, we investigated whether the mitogen‐activated protein (MAP) kinase superfamily is involved in the bone morphogenetic protein (BMP)‐4‐stimulated synthesis of osteocalcin in osteoblast‐like MC3T3‐E1 cells. BMP‐4 dose‐dependently stimulated osteocalcin synthesis. BMP‐